| Literature DB >> 26538000 |
Abstract
Various amines, such as triethylamine and N,N-dimethylethylamine, have been reported to cause glaucopsia in workers employed in epoxy, foundry, and polyurethane foam industries. This symptom has been related to corneal edema and vesicular collection of fluid within the corneal subepithelial cells. Exposure to amine vapors for 30 min to several hours leads to blurring of vision, a blue-grey appearance of objects, and halos around lights, that are probably reversible. Concentration-effect relationships have been established. The visual disturbance is considered a nuisance, as it could cause onsite accidents, impair work efficiency, and create difficulties in driving back home. Occupational exposure limits have been established for some amines, but there is shortage of criteria. Volatility factors, such as vapor pressure, should be considered in industrial settings to prevent human ocular risks, while trying to reduce levels of hazardous amines in the atmosphere.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26538000 PMCID: PMC4821893 DOI: 10.2486/indhealth.2015-0071
Source DB: PubMed Journal: Ind Health ISSN: 0019-8366 Impact factor: 2.179
The list of amines that may cause human glaucopsia
| Chemical name | Abbreviation | CAS No. | Chemical group | Molecular form | MW | MP (°C) | BP (°C) | VP (mmHg) |
|---|---|---|---|---|---|---|---|---|
| Dimethylamine | DMA | 124-40-3 | secondary amine | (CH3)2NH | 45.1 | –92.2 | 6.8 | 1,520 |
| N,N-Dimethylethylamine | DMEA | 598-56-1 | tertiary amine | (CH3)3CH2N | 73.1 | –140 | 36.5 | 418 |
| Triethylamine | TEA | 121-44-8 | tertiary amine | (CH3CH2)3N | 101.2 | –114.7 | 89.3 | 57.1 |
| Triethylenediamine | TEDA | 280-57-9 | tertiary diamine | (CH2)6N2 | 112.2 | 158 | 174 | 0.742 |
| Bis[2-dimethylaminoethyl]ether | DMAEE | 3033-62-3 | tertiary diamine | O[(CH3)2(CH2)2N]2 | 160.3 | NA | 189 | 0.748 |
| N,N,N’,N’-Tetramethyl-1,6-hexandianine | TMHDA | 111-18-2 | tertiary diamine | [(CH3)2(CH2)3]2N2 | 172.3 | –46 | 209.5 | 0.202 |
| Morpholine | MP | 110-91-8 | heterocyclic amine | O(CH2)4NH | 87.1 | –4.8 | 128 | 10.1 |
| N-Methylmorpholine | MMP | 109-02-4 | heterocyclic amine | O(CH2)4CH3N | 101.2 | –66 | 115.5 | 18 |
| N-Ethylmorpholine | EMP | 100-74-3 | heterocyclic amine | O(CH2)5CH3N | 115.2 | –62.8 | 138.5 | 6.1 |
| N,N-Dimethylaminoethanolamine | DMAEA | 108-01-0 | Alkanol amine | HO(CH3)2(CH2)2N | 89.1 | –70 | 135 | 100 |
| N,N-Dimethylisopropanolamine | DMIPA | 108-16-7 | Alkanol amine | HO(CH3)3CH2CHN | 103.2 | –85 | 96 | 8 |
Articles describing human glaucopsia caused by DMEA
| Author (s) | Year | Type | Reference |
|---|---|---|---|
| Schmitter | 1977 | Original | |
| Albrecht & Stephenson | 1988 | Review | |
| Warren & Selchan | 1988 | Original | |
| Ståhlbom | 1994 | Original | |
| Ballantyne | 2004 | Review | |
| US-NIOSH | 1984 | Report | |
| US-NIOSH | 1984 | Report | |
| US-NIOSH | 1986 | Report | |
| US-NIOSH | 1987 | Report | |
| US-NIOSH | 1987 | Report |
Articles describing human glaucopsia caused by TEA
| Author (s) | Year | Type | Reference |
|---|---|---|---|
| Amor | 1949 | Original | |
| Schmitter | 1977 | Original | |
| Åkesson | 1985 | Original | |
| Åkesson | 1986 | Original | |
| Potts | 1986 | Original | |
| Albrecht & Stephenson | 1988 | Review | |
| Åkesson | 1988 | Original | |
| Warren Selchan | 1988 | Original | |
| Åkesson | 1989 | Original | |
| Åkesson & Skerfving | 1990 | Original | |
| Reilly | 1995 | Original | |
| Jävinen & Hyvärinen | 1997 | Original | |
| Ballantyne | 1999 | Review | |
| Jävinen | 1999 | Original | |
| ACGIH | 2001 | Review | |
| Yoshida | 2001 | Letter | |
| Ballantyne | 2004 | Review | |
| Hathaway | 2004 | Review |
Industrial processes for glaucopsia and irritation hazards
| Process | Amines | References (glaucopsia) | References (irritation) |
|---|---|---|---|
| PU foam | TEA, TEDA, DMAEE, TMHDA, MP, MMP, EMP,
DEtA | ||
| Foundry | DMEA, TEA, HMTA | ||
| Epoxy | Other amines | ||
| Printing | DMAEA, DMIPA, | ||
| Others | DMA, MMP, EMP |
*DEtA: diethanolamine
**HMTA: hexamethylenetetramine
Other amines include m-phenylenediamine, triethylenetetramine, dimethylethanolamine, diethylenetriamine, dimethylaminopropylamine, diethylaminopropylamine, and benzyldimethylamine
Amine exposure levels causing glaucopsia in workers
| Reference | Amines | Process | Type | Samples | Exposure range | Glaucopsia | Additional findings | |
|---|---|---|---|---|---|---|---|---|
| Warren & Selchan | TEA | Foundry | Onsite | 31 (TWA) | 2.6–3.6 ppm* (GM: 3.1 ppm) | + | No glaucopsia at less than 5 ppm | |
| Foundry | Onsite | 69 (STEL) | 4.5–5.9 ppm | + | ||||
| Schmitter | Foundry | Onsite | 38 | 0.1–11.8 ppm (mean: 3.3 ppm) | + | |||
| Reilly | Foundry | Onsite | 17 | 0.1–4.9 ppm (mean: 1.9 ppm) | + | Common symptom at >2.5 ppm | ||
| Jävinen & Hyvärinen | Foundry | Onsite | NA | 0.1–14.5 ppm (median: 6.4 ppm) | + | |||
| Åkesson | PU | Onsite | 5 (TWA) | 1.2–8.0 ppm (mean: 3.2 ppm) | + | 2.4–3.6 ppm (TWA) may cause glaucopsia | ||
| NA (STEL) | ND-5.8 ppm (mean : NA) | |||||||
| Åkesson | Chamber experiment | 2 | 2.4/4.4/8.2/11.6 ppm | +/− | Glaucopsia at 4.4 ppm and higher | |||
| Åkesson | Chamber experiment | 5 | 2.4/4.8/8.5/12.8 | +/− | Glaucopsia at 4.8 ppm and higher | |||
| Jävinen | Chamber experiment | 4 | 0.72/1.58/9.8 ppm | +/− | Glaucopsia at 1.58 ppm and higher | |||
| Åkesson | Chamber experiment | 4 | 4.8 ppm | + | Occurrence of glaucopsia | |||
| Warren & Selchan | DMEA | Foundry | Onsite | 54 (TWA) | 5.7–6.9 ppm* (GM: 6.3 ppm) | + | No glaucopsia at less than 5 ppm | |
| Foundry | Onsite | 151 (STEL) | 10.2–11.2.9 ppm* (GM: 10.7 ppm) | + | ||||
| Schmitter | Foundry | Onsite | 26 | 0.001–12.3 ppm (mean: 2.6 ppm) | + | |||
| US-NIOSH | Foundry | Onsite | 4 | 0.4–0.8 ppm (mean: 0.6 ppm) | + | |||
| US-NIOSH | Foundry | Onsite | 9 | 1.8–8.8 ppm (mean: 4.4 ppm) | + | |||
| US-NIOSH | Foundry | Onsite | NA | NA | + | Glaucopsis at 2 ppm (TWA) or higher, 9.7 ppm (STEL) or higher | ||
| US-NIOSH | Foundry | Onsite | 63 (TWA) | ND-8.0 ppm (mean: 2.3 ppm) | + | |||
| 30 (STEL) | ND-9.7 ppm (mean: 1.6 ppm) | |||||||
| Ståhlbom | Chamber experiment | 4 (TWA) | 3.3/6.6/13.3/16.6 ppm | +/− | No glaucopsia at less than 6.6 ppm | |||
| Chamber experiment | 30 (STEL) | 26.7/53.3 ppm | - | No glaucopsia with eye irritation | ||||
| Foundry | Onsite | 12 | 0.16–9.3 ppm (mean: 1.2 ppm) | + | Glaucopsis at 7.6–9.3 ppm | |||
| Belin | TEDA | PU | Onsite | 7 | 0.017–0.11 ppm (mean: 0.08 ppm) | + | ||
| US-NIOSH | PU | Onsite | NA | NA | + | Failed to detect amines in the air | ||
| Jang | PU | Onsite (Pre) | 29 | ND-0.26 ppm (mean: 0.06 ppm) | + | Isocyanate and aldehydes detected | ||
| Jang & Park | PU | Onsite (Post) | 29 | ND-0.08 ppm (mean: 0.03 ppm) | - | Aldehyde levels also reduced | ||
| US-NIOSH | DMAEA | Printing | Onsite (Pre) | 110 | 0.05–1.24 ppm (mean: 0.66 ppm) | +/− | ||
| US-NIOSH | Printing | Onsite (Post) | 64 | 0.01–1.37 ppm (mean: 0.76 ppm) | - | DMAEA was not related to glaucopsia | ||
| US-NIOSH | DMIPA | Printing | Onsite (Pre) | 110 | 0.16–4.0 ppm (mean: 1.65 ppm) | +/− | Mean DMIPA (1.83 ppm, N=96) caused glaucopsia | |
| US-NIOSH | Printing | Onsite (Post) | 64 | 0.01–0.09 ppm (mean: 0.02 ppm) | - | DMIPA related to glaucopsia | ||
| Jang | TMHDA | PU | Onsite (Pre) | 29 | ND-0.29 ppm (mean: 0.07 ppm) | + | Isocyanate and aldehydes detected | |
| Jang & Park | PU | Onsite (Post) | 29 | ND-0.002 ppm (mean: 0.01 ppm) | - | Aldehyde levels also reduced | ||
| US-NIOSH | DMAEE | PU | Onsite | NA | NA | + | Failed to detect amines in the air | |
| Belin | MMP | PU | Onsite | 7 | 3.2–7.6 ppm (median: 6.9 ppm) | + | MMP might cause glaucopsia | |
* Upper and lower 95% confidence limits of the GM
Occupational exposure limits of amines for glaucopsia
| Chemical name | ACGIH-TLVs73) | OSHA-PELs74) | NIOSH-RELs74) | AIHA-WEEL74) | UK HSL-WEL86) | German-MAKs74) | Skin notation | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TLV | STEL | TLV | STEL | TLV | STEL | TLV | STEL | TLV | STEL | TLV | STEL | ||
| Ethylamine | 5 | 15 | 10 | - | 10 | - | - | - | 2 | 6 | 5 | C10 | ACGIH |
| Isopropylamine | 5 | 10 | 5 | - | - | - | - | - | - | - | 5 | C10 | |
| Ethylenediamine | 10 | - | 10 | - | 10 | - | - | - | - | - | - | - | ACGIH |
| Dimethylamine* | 5 | 15 | 10 | - | 10 | - | 1 | 3 | 2 | 6 | 2 | - | |
| Diethylamine | 5 | 15 | 25 | - | 10 | 25 | - | - | 5 | 10 | 5 | C10 | ACGIH |
| Diisopropylamine | 5 | - | 5 | - | 5 | - | - | - | 5 | - | - | - | ACGIH/OSHA/NIOSH |
| Triethylamine | 1 | 3 | 25 | - | - | - | - | - | 2 | 4 | 1 | ACGIH/HSL | |
| Bis (2-dimethylaminoethyl) ether* | 0.005 | 0.15 | - | - | - | - | - | - | - | - | ACGIH | ||
| Morpholine* | 20 | - | 20 | - | 20 | 30 | 10 | - | 10 | 20 | - | - | ACGIH/OSHA/NIOSH/HSL |
| N-Ethylmorpholine* | 5 | - | 20 | - | 5 | - | - | - | 5 | 20 | - | - | ACGIH/OSHA/NIOSH/HSL |
*Amines listed in Table 1 as glaucopsia chemicals, **Notice of intended change in 2014 TLVs
Sampling and analytical methods for glaucopsia amines
| Reference | Year | Amines | Sampling | Analysis | Findings |
|---|---|---|---|---|---|
| Audursson & Mathiasson | 1983 | MMP, DMAEE | Acid-filled impinger | GC/TSD | Testing for sampling/analytical measure |
| Audunsson & Mathiasson | 1984 | DMA, TEA, MMP | - | GC/TSD | Testing for analytical measure |
| Hansén | 1985 | DMEA | Acid-filled impinger/Silica gel | Isotachophoresis | Comparing sampling/analytical measure |
| Hansén | 1986 | MMP | Acid-filled impinger | Isotachophoresis | Testing for sampling/analytical measure |
| Boeniger | 1987 | TEDA | Acid-filled impinger | GC/TEA | Impinger method could be complementary |
| Thermosorb/A | |||||
| Andersson & Andersson | 1989 | DMEA, TEA | Char coal tube | GC/NPD & FID | Charcoal for methyl/ethyl aliphatic amines |
| EMP | Aberlite XAD-2 | XAD-2 for long chain amines | |||
| Andersson & Andersson | 1991 | TEDA | Aberlite XAD-2 | GC/NPD | XAD-2 is recommended for TEDA |
| Foley | 1991 | TEA, DMAEE, EMP | Thermosorb/A | GC/NPD | Thermosorb/A be use with caution |
| Rampel | 2008 | TEA | H3PO4 impregnated sampler | LC/MS | Testing for sampling/analytical measure |
| US-NIOSH NMAM 2010 | 1994 | Aliphatic amines | Silica gel | GC/FID | Recommended method |
| US-NIOSH NMAM 2002 | 1994 | Aromatic amines | Silica gel | GC/FID | Recommended method |
| US-NIOSH NMAM 2007 | 1994 | Aminoethanol compounds I | Silica gel | GC/FID | Recommended method |
| US-NIOSH NMAM 3509 | 1994 | Aminoethanol compounds II | Impinger with hexanesulfonic acid | IC | Recommended method |
| US-OSHA 34 | 1982 | DMA | 10% NBD chloride coated XAD-7 | HPLC/Fl or Vis | Recommended method |
| US-OSHA PV 2060 | 1993 | TEA | 10% H3PO4 coated XAD-7 | GC/FID | Recommended method |
| US-OSHA PV 2123 | 2003 | MP | 10% H3PO4 coated XAD-7 | GC/FID | Recommended method |
| US-OSHA IMIS 1225 | NA | NMP | Silica gel | GC/FID | Recommended method |
| UK-HSL MDHS75/2 | NA | Aromatic amines | Acid-coated GF filter with Tenax | HPLC/UV | Recommended method |
*GC/FID: Gas Chromatograph/Flame Ionization Detector, GC/MS: Gas Chromatograph/Mass Spectrometer, GC/NPD: Gas Chromatograph/Nitrogen Phosphorous Detector, GC/TEA: Gas Chromatograph/Thermal Energy Analyzer, 4GC/TSD: Gas Chromatograph/Thermionic Specific Detector, HPLC/Fl or Vis: High Performance Liquid Chromatograph/Florescence or Visible detector, HPLC/UV: High Performance Liquid Chromatograph/Ultraviolet detector, IC: Ion Chromatograph, LC/MS: Liquid Chromatograph/Mass Spectrometer.